ATLASAtossa Therapeutics (ATOS) earnings date: Nov 11, 2026
Atossa Therapeutics (ATOS) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 11, 2026. Analysts expect EPS of -$0.86.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on ATOS
| Last price | $2.17 (-2.7%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.8% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Atossa Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Atossa Therapeutics reports on Nov 11, 2026. One email the day before, with ATLAS’s read on Atossa Therapeutics. You can switch it off at any time.
Alert me before ATOS reportsFree to start. Creating an account takes under a minute.
ATOS earnings at a glance
| Next report (confirmed) | Wed, Nov 11, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.86 |
| Last report | Aug 7, 2026 · Beat |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | +12.7% |
| Average move around a report | ±6.0% (last 5) |
| Sector | Healthcare · Biotechnology |
Atossa Therapeutics earnings history: last 5 reports
Atossa Therapeutics last reported on Aug 7, 2026: EPS of -$0.95 against an estimate of -$1.10 (+13.6% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 7, 2026 | -$1.10 | -$0.95 | +13.6% | Beat | -2.1% |
| Jun 22, 2026 | -$10.00 | -$3.36 | +66.4% | Beat | -5.5% |
| Jun 4, 2026 | $1.45 | $1.64 | +13.1% | Beat | -4.9% |
| May 8, 2026 | -$0.99 | -$1.11 | -12.1% | Miss | -3.0% |
| Mar 25, 2026 | -$1.14 | -$1.34 | -17.5% | Miss | -14.5% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for ATOS
See the fair value, the probability range and the earnings history of Atossa Therapeutics on its ATLAS page.
Atossa Therapeutics (ATOS) stock analysisPlans from €3.99 a month.
Atossa Therapeutics earnings: frequently asked questions
When does Atossa Therapeutics (ATOS) report earnings?
Atossa Therapeutics is scheduled to report on Wednesday, November 11, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for ATOS?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.86 per share (USD). Estimates can change before the report.
How often does ATOS beat earnings estimates?
Of its last 5 reports with a recorded result, Atossa Therapeutics beat the EPS estimate 3 times; the average surprise was +12.7%. Past results do not predict the next one.
How much does ATOS move around earnings?
Over its last 5 reports the stock moved an average of 6.0% (absolute, from the close before the report day to the close after it), and finished higher 0 of 5 times.
Did Atossa Therapeutics beat earnings estimates last quarter?
Atossa Therapeutics last reported on Aug 7, 2026: EPS of -$0.95 against an estimate of -$1.10 (+13.6% surprise), a beat.
How much does ATOS usually move in a day?
On a normal trading day the ATLAS model puts ATOS’s one-day range at about ±4.8%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 11, 2026
Educational information, not investment advice. Disclaimer